Laparoscopic Versus Transabdominal Ultrasound in Morbidly Obese Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00971750|
Recruitment Status : Completed
First Posted : September 4, 2009
Results First Posted : July 2, 2012
Last Update Posted : July 11, 2012
|Condition or disease|
|Cholelithiasis Ultrasonography Laparoscopic Gastric Bypass|
|Study Type :||Observational|
|Actual Enrollment :||253 participants|
|Official Title:||Comparison of Laparoscopic Ultrasound to Transabdominal Ultrasound for the Detection of Gallbladder Pathology in the Bariatric Surgical Population.|
|Study Start Date :||October 2003|
|Actual Primary Completion Date :||October 2010|
|Actual Study Completion Date :||October 2011|
Ultrasound Study Group
Patients with no history of gallbladder surgery who are undergoing elective laparoscopic roux-en-Y gastric bypass that have consented to undergo a preoperative transabdominal ultrasound in addition to routine preoperative assessment for surgery.
- Cholelithiasis on Transabdominal Ultrasound Versus Laparoscopic Ultrasound. [ Time Frame: transabdominal measurements within 30 days prior to surgery; laparoscopic ultrasound measurements are completed intraoperatively ]Number of patients with cholelithiasis.
- Polyps on Transabdominal and Laparoscopic Ultrasound [ Time Frame: 6 years ]Number of patients with polyps.
- Common Bile Duct (CBD) Diameter Measured by Transabdominal Ultrasound Versus Laparoscopic Ultrasound. [ Time Frame: transabdominal measurements will be done within 30 days prior to surgery; laparoscopic ultrasound measurements are completed intraoperatively ]Mean CBD diameter.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00971750
|United States, Wisconsin|
|Gundersen Lutheran Health System|
|La Crosse, Wisconsin, United States, 54601|
|Principal Investigator:||Shanu N Kothari, MD||Gundersen Lutheran Health System|